Non-progression of cervical intraepithelial neoplasia estimated from population-screening data
1997

Non-progression of cervical intraepithelial neoplasia from screening data

Sample size: 1595 publication Evidence: moderate

Author Information

Author(s): AB Bos, M van Ballegooijen, GJ van Oortmarssen, ME van Marie, JDF Habbema, E Lynge

Primary Institution: Erasmus University Rotterdam

Hypothesis

What are the rates of non-progression and duration of preclinical neoplastic lesions of the cervix?

Conclusion

At least 48% of preclinical lesions in women aged 25-50 do not progress to clinical cancer.

Supporting Evidence

  • 24% of preclinical lesions progressed, 39% regressed, and 38% remained stable.
  • The estimated mean duration of preclinical lesions was 16 years.
  • Detection rates were low compared to current rates in several countries.

Takeaway

Most women with early signs of cervical cancer won't get worse, and many will stay healthy for a long time.

Methodology

Data from cervical smears and biopsies in Maribo County, Denmark, were analyzed to estimate non-progression rates and duration of preclinical lesions.

Potential Biases

Potential underestimation of non-progression due to undetected regressive lesions.

Limitations

The study assumes no new preclinical lesions develop after age 50, which may not be accurate.

Participant Demographics

Women aged 25-50 in Maribo County, Denmark.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication